Trident Lifeline was incorporated in 2014. It is engaged in the marketing of pharmaceutical products in domestic as well as international markets. The company is also engaged in the distribution of pharmaceutical products through a third-party distribution network.
| Bidding Dates |
|---|
| 26 Sep 2022 - 29 Sep 2022 |
| Subscription |
|---|
| 1.34x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,21,200 | 1 | 1 | 1200 | 3.5 M | ₹101 | 69.57 % | ₹353.4 M | RHP DOC |
Trident Lifeline IPO SUBSCRIPTION STATUS
29 Sep '22Trident Lifeline IPO overall subscription rate was 1.34 times the total available shares
Trident Lifeline IPO retail subscription rate was 0.98 times in the retail segment
Trident Lifeline IPO non-institutional investor subscription rate was 1.69 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
29 Sep 2022 (Day 4) | 0.98x | 1.69x | - |
28 Sep 2022 (Day 3) | 0.52x | 0.63x | - |
27 Sep 2022 (Day 2) | 0.33x | 0.43x | - |
26 Sep 2022 (Day 1) | 0.06x | 0.07x | - |
Trident Lifeline FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from operations (Rs in millions) | Cash Flow from operations (Rs in millions) | Free Cash flow (Rs in millions) |
| FY22 | 22.5 | 217.7 | -2.6 | -7.1 |
Trident Lifeline IPO SUBSCRIPTION STATUS DETAILS
Trident Lifeline had 3.5 M shares on offer
Trident Lifeline IPO offer price was ₹101
Trident Lifeline IPO minimum Investment was ₹121200
Trident Lifeline IPO issue size was ₹ 353.4 M
Trident Lifeline had a minimum lot size of 1200 Shares per application
Trident Lifeline NUMBER OF SHARES ON OFFER
Trident Lifeline IPO IMPORTANT DATES
| Issue Open Date | 26 Sep 2022 |
| Issue close Date | 29 Sep 2022 |
| Allotment Date | 04 Oct 2022 |
| Refund Date | 06 Oct 2022 |
| Demat Account Credit Date | 07 Oct 2022 |
| Listing Date | 10 Oct 2022 |
| Listing on Exchange(s) | BSE |
| Trident Lifeline Allotment Status | Exchange |
Trident Lifeline IPO subscription opened on 26 Sep 2022, and closed on 29 Sep 2022
IPO allotment for Trident Lifeline was finalized on Tuesday, 04 Oct 2022
IPO listing for Trident Lifeline was on BSE on Monday, 10 Oct 2022
Trident Lifeline IPO LISTING GAINS
| Issue Price (adjusted) | 101.0 |
| Listing Open Price | 105.0 |
| Listing Close Price | 108.2 |
| Listing Gain% | 4.0% |
| Current Gain% | 153.5% |
Trident Lifeline Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trident Lifeline Ltd. | 256 | 294.4 | 15.9 | 0.2 | 2.2 | 19 | 8 | 138.3 | 45.3 | 19 | 62.1 | 16.1 | 86.5 |
| Sun Pharmaceutical Industries Ltd. | 1948.6 | 467534.4 | 38.7 | 2.3 | 7.8 | 13.7 | 10.6 | 60433.8 | 10.8 | 11479.4 | 5 | 50.4 | 16.6 |
| Divi's Laboratories Ltd. | 8282 | 219861.1 | 75.2 | 2.8 | 19.6 | 15.3 | 12.8 | 11067 | 14 | 2568 | 17.2 | 110.2 | 26.8 |
| Torrent Pharmaceuticals Ltd. | 4904.5 | 186551.4 | 85.5 | 9.6 | 11.9 | 25.8 | 4.9 | 13886.2 | 20.3 | 2163.4 | 13.2 | 57.3 | 8.9 |
| Cipla Ltd. | 1467.8 | 118576.7 | 35.2 | -0.9 | 4.2 | 11.3 | 9.1 | 29044.6 | 2.2 | 3879.2 | -26.4 | 41.7 | -37.5 |
| Zydus Lifesciences Ltd. | 1113.5 | 112044.2 | 22.2 | 2.3 | 4.1 | 18.6 | 9.6 | 27657.9 | 17.6 | 5040 | 11.4 | 50.1 | 9.6 |
Trident Lifeline INFORMATION ON IPO ISSUE
About Trident Lifeline
Trident Lifeline was incorporated in 2014. It is engaged in the marketing of pharmaceutical products in domestic as well as international markets. The company is also engaged in the distribution of pharmaceutical products through a third-party distribution network.
Object of the Issue
- To meet working capital requirements
- Product registration in the international markets
- General corporate purpose
- To meet public issue expenses
Trident Lifeline - PROMOTERS
| Name |
|---|
| Hardik Jigishkumar Desai |
| Mayurkumar Mansukhbhai Gajera |
| Rupaben C Jariwala |
| Rinkal Mayurbhai Gajera |
| Tarang Nathabhai Gajera |
| Mohak Nathabhai Gajera |
Trident Lifeline Lead Manager to the Issue
Beeline Broking Limited
mb@beelinemb.com
Trident Lifeline Registrar to the Issue
Link Intime India Private Limited
trilife.ipo@linkintime.co.in
Trident Lifeline Strengths
Experienced promoters and management team
The management team is experienced in the industry in which it operates and has been responsible for the growth of operations and financial performance
Wide range of products
The company deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders and toothpaste. The product portfolio comprises of a wide range of drugs like anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure and many more.
Quality assurance
The company is in the ongoing process of building and sustaining relationships and it has obtained ISO 9001:2015 Certification for the Quality Management System from BQC Assessments Private Limited, Delhi, India
Trident Lifeline Risks
Tax proceedings
One of the group companies is involved in tax proceedings and actions by a statutory authority which are currently pending at various stages. Also, a case for the recovery of dues has been filed by a director of the company.
Reliant on third parties
The company relies on third parties for manufacturing products sold by company.
IPO FAQs
The promoters of the company are Hardik Jigishkumar Desai, Mayurkumar Mansukhbhai Gajera, Rupaben C Jariwala, Rinkal Mayurbhai Gajera, Tarang Nathabhai Gajera and Mohak Nathabhai Gajera.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 101.0 - 101.0.
The IPO application opens on Sep 26, 2022 and closes on Sep 29, 2022.
The minimum lot size for the IPO is 1200. The maximum lot size for the IPO is 1200.
For all category investors, the minimum application amount for this IPO is Rs. 121,200.0, the maximum value for this IPO is Rs 121,200.0.
This IPO will be allotted on Oct 04, 2022.
The refund will be credited to your account on Oct 06, 2022.
The allotted shares will be credited to your demat on Oct 07, 2022.
Trident Lifeline Ltd.’s shares listed on the stock exchanges on Oct 10, 2022.